Publications by authors named "Minjun Cao"

Claim this Profile
N
Nanodiamond-based layer-by-layer nanohybrids mediate targeted delivery of miR-34a for triple negative breast cancer therapy.
Yang Xia, Xiongwei Deng, Minjun Cao, Sha Liu, Xiaofei Zhang

RSC Adv· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first murine zygotic transcription is promiscuous and uncoupled from splicing and 3' processing.
Ken-Ichiro Abe, Ryoma Yamamoto, Vedran Franke, Minjun Cao, Yutaka Suzuki

EMBO J· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradable hyaluronic acid/protamine sulfate interpolyelectrolyte complexes as miRNA-delivery nanocapsules for triple-negative breast cancer therapy.
Shihua Wang, Minjun Cao, Xiongwei Deng, Xiangqian Xiao, Zhaoxia Yin

Adv Healthc Mater· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Xiongwei Deng, Minjun Cao, Jiakun Zhang, Kelei Hu, Zhaoxia Yin

Biomaterials· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
Fang Zhang, Zhiping Yang, Minjun Cao, Yinsheng Xu, Jintao Li

Cancer Lett· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protamine sulfate-nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells.
Minjun Cao, Xiongwei Deng, Shishuai Su, Fang Zhang, Xiangqian Xiao

Nanoscale· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis